|
NZ535349A
(en)
|
2002-03-08 |
2007-01-26 |
Signal Pharm Inc |
JNK inhibitors with chemotherapeutic agents in a combination therapy for treating or preventing cancer and other proliferative disorders in refractory patients in particular
|
|
SE0203070D0
(en)
*
|
2002-10-16 |
2002-10-16 |
Astrazeneca Ab |
Novel compounds
|
|
US7375228B2
(en)
*
|
2003-03-17 |
2008-05-20 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
SE0300908D0
(sv)
*
|
2003-03-31 |
2003-03-31 |
Astrazeneca Ab |
Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
|
|
SE0301446D0
(sv)
*
|
2003-05-16 |
2003-05-16 |
Astrazeneca Ab |
New Compounds
|
|
SE0301698D0
(sv)
*
|
2003-06-10 |
2003-06-10 |
Astrazeneca Ab |
Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
|
|
SE0301701D0
(sv)
*
|
2003-06-10 |
2003-06-10 |
Astrazeneca Ab |
Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
|
|
SE0301699D0
(sv)
|
2003-06-10 |
2003-06-10 |
Astrazeneca Ab |
Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
|
|
US7465815B2
(en)
|
2003-06-26 |
2008-12-16 |
Takeda Pharmaceutical Company Limited |
Cannabinoid receptor modulator
|
|
US7157471B2
(en)
*
|
2003-08-25 |
2007-01-02 |
Boehringer Ingelheim International Gmbh |
Haloalkyl- and piperidine-substituted benzimidazole-derivatives
|
|
WO2005021547A2
(en)
*
|
2003-08-28 |
2005-03-10 |
Pharmaxis Pty Ltd. |
Heterocyclic cannabinoid cb2 receptor antagonists
|
|
SE0302573D0
(sv)
*
|
2003-09-26 |
2003-09-26 |
Astrazeneca Ab |
Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
|
|
SE0302571D0
(sv)
*
|
2003-09-26 |
2003-09-26 |
Astrazeneca Ab |
Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
|
|
SE0302572D0
(sv)
*
|
2003-09-26 |
2003-09-26 |
Astrazeneca Ab |
Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
|
|
SE0302570D0
(sv)
*
|
2003-09-26 |
2003-09-26 |
Astrazeneca Ab |
Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
|
|
WO2005037798A2
(en)
*
|
2003-10-16 |
2005-04-28 |
Cara Therapeutics, Inc |
Amide or thiomide derivatives and their use in the treatment of pain
|
|
EP1797074A4
(en)
*
|
2004-09-24 |
2009-04-01 |
Astrazeneca Ab |
COMPOUNDS, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND APPLICATIONS THEREOF IIII
|
|
CN101052639B
(zh)
*
|
2004-09-24 |
2010-10-27 |
阿斯利康(瑞典)有限公司 |
苯并咪唑衍生物、含有它们的组合物、其制备方法和其用途
|
|
JP2008514592A
(ja)
*
|
2004-09-24 |
2008-05-08 |
アストラゼネカ・アクチエボラーグ |
ベンゾイミダゾール誘導体、それらを含有する組成物、それらの製造及びそれらの使用ｉｉｉ
|
|
WO2006033631A1
(en)
*
|
2004-09-24 |
2006-03-30 |
Astrazeneca Ab |
Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
|
|
EP1797075A1
(en)
*
|
2004-09-24 |
2007-06-20 |
AstraZeneca AB |
Benzimidazole derivatives and their use as cannabinoid receptor ligands
|
|
EP1797070A1
(en)
*
|
2004-09-24 |
2007-06-20 |
AstraZeneca AB |
Compounds, compositions containing them, preparations thereof and uses thereof ii
|
|
BRPI0515897A
(pt)
*
|
2004-09-24 |
2008-08-12 |
Astrazeneca Ab |
composto, uso do mesmo, composição farmacêutica, e, método para a terapia de dor em um animal de sangue quente, e para a preparação de um composto
|
|
JP2008514594A
(ja)
*
|
2004-09-24 |
2008-05-08 |
アストラゼネカ・アクチエボラーグ |
ベンゾイミダゾール誘導体及びカンナビノイド受容体リガンドとしてのその使用ｉ
|
|
JP2008514590A
(ja)
*
|
2004-09-24 |
2008-05-08 |
アストラゼネカ・アクチエボラーグ |
ベンゾイミダゾール誘導体、それを含む組成物、その製造方法及びその使用
|
|
KR100912146B1
(ko)
|
2004-10-27 |
2009-08-14 |
에프. 호프만-라 로슈 아게 |
인돌 또는 벤즈이미다졸 유도체
|
|
CA2586179C
(en)
*
|
2004-11-02 |
2011-02-08 |
Pfizer Inc. |
Sulfonyl benzimidazole derivatives
|
|
SE0402762D0
(sv)
*
|
2004-11-11 |
2004-11-11 |
Astrazeneca Ab |
Indazole sulphonamide derivatives
|
|
SE0402763D0
(sv)
*
|
2004-11-11 |
2004-11-11 |
Astrazeneca Ab |
Nitro indazole derivatives
|
|
EP1861377B1
(en)
*
|
2005-03-15 |
2010-12-29 |
Pfizer, Inc. |
Benzimidazolone derivatives as cb2 receptor ligands
|
|
EP1874283A4
(en)
|
2005-04-28 |
2011-11-02 |
Ferring Bv |
USE OF NEW COMPOUNDS FOR THE TREATMENT OF IBD
|
|
UY30048A1
(es)
|
2005-12-23 |
2007-07-31 |
Astrazeneca Ab |
Derivados sustituidos de la n,2-(1h-benzimidazol-1-il) acetamida, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
|
|
WO2007091950A1
(en)
*
|
2006-02-07 |
2007-08-16 |
Astrazeneca Ab |
Benzimidazoles and imidazopyridines useful in the treatment of diseases or disorders associated with cannabinoid receptor 2 (cb2) such as pain
|
|
US7700618B2
(en)
|
2006-03-06 |
2010-04-20 |
Pfizer Inc |
Sulfonyl benzimidazole derivatives
|
|
TW200745049A
(en)
|
2006-03-23 |
2007-12-16 |
Astrazeneca Ab |
New crystalline forms
|
|
TW200808769A
(en)
*
|
2006-04-18 |
2008-02-16 |
Astrazeneca Ab |
Therapeutic compounds
|
|
TW200808772A
(en)
*
|
2006-06-13 |
2008-02-16 |
Astrazeneca Ab |
Therapeutic compounds
|
|
CA2654246A1
(en)
*
|
2006-07-04 |
2008-01-10 |
Janssen Pharmaceutica N.V. |
Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
|
|
TWI433839B
(zh)
|
2006-08-11 |
2014-04-11 |
Neomed Inst |
新穎的苯并咪唑衍生物290
|
|
FR2907784B1
(fr)
*
|
2006-10-27 |
2009-02-13 |
Sod Conseils Rech Applic |
Derives phenyliques et leur utilisation comme medicament
|
|
WO2009116074A2
(en)
*
|
2008-02-13 |
2009-09-24 |
Cadila Healthcare Limited |
Substituted benzimidazoles as cannabinoid modulator
|
|
EP2456428A1
(en)
|
2009-07-23 |
2012-05-30 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Selective cb2 receptor agonists for use in the prevention or treatment of alcoholic liver disease
|
|
US20110086853A1
(en)
*
|
2009-10-08 |
2011-04-14 |
William Brown |
Therapeutic Compounds
|
|
CA2789950C
(en)
|
2010-02-18 |
2018-09-04 |
High Point Pharmaceuticals, Llc |
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
|
|
US8759535B2
(en)
|
2010-02-18 |
2014-06-24 |
High Point Pharmaceuticals, Llc |
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
|
|
WO2013012848A1
(en)
|
2011-07-18 |
2013-01-24 |
Merck Patent Gmbh |
Benzamides
|
|
CN102977056B
(zh)
*
|
2012-11-28 |
2014-11-26 |
深圳万乐药业有限公司 |
N-苄氧羰基-3-氟-4-吗啉基苯胺的合成方法
|
|
WO2016089648A1
(en)
|
2014-12-01 |
2016-06-09 |
Vtv Therapeutics Llc |
Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
|
|
CN107531679B
(zh)
*
|
2016-03-18 |
2021-07-02 |
江苏恒瑞医药股份有限公司 |
芳香酰胺类衍生物、其制备方法及其在医药上的应用
|